Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 13;8(1):125-134.
doi: 10.1002/lio2.994. eCollection 2023 Feb.

Five-year survival outcomes in oropharyngeal squamous cell carcinoma following transoral laser microsurgery

Brooke Turner  1 , Colin MacKay  1   2 , S Mark Taylor  1 , Matthew Hall Rigby  1
Affiliations

Five-year survival outcomes in oropharyngeal squamous cell carcinoma following transoral laser microsurgery

Brooke Turner et al. Laryngoscope Investig Otolaryngol. .

Abstract

Objective: To determine the 5-year survival outcomes of patients with oropharyngeal cancer treated with transoral laser microsurgery at our institution.

Methods: A prospective longitudinal cohort study of all cases of oropharyngeal squamous cell cancer or clinically unknown primaries diagnosed at our institution between September 1, 2014, to December 31, 2019, treated with primary transoral laser microsurgery were analyzed. Patients with a previous history of head and neck radiation were excluded from analysis. Kaplan-Meier survival curves were used to estimate 5-year overall survival, disease-specific survival, local control, and recurrence free survival rates in oropharyngeal squamous cell carcinoma.

Results: Of 142 patients identified, 135 met criteria and were included in the survival analysis. Five-year local control rates in p16 positive and negative disease were 99.2% and 100%, respectively, with one locoregional failure in the p16 positive cohort. Five-year overall survival, disease-specific survival, and recurrence free survival in p16 positive disease were 91%, 95.2%, and 87% respectively (n = 124). Five-year overall survival, disease-specific survival, and recurrence free survival in p16 negative disease were 39.8%, 58.3%, and 60%, respectively (n = 11). The permanent gastrostomy tube rate was 1.5% and zero patients received a tracheostomy at the time of surgery. One patient (0.74%) required a return to the OR for a post-operative pharyngeal bleed.

Conclusion: Transoral laser microsurgery is a safe primary treatment option for oropharyngeal squamous cell carcinoma with high 5-year survival outcomes, notably in p16 positive disease. More randomized trials are needed to compare survival outcomes and associated morbidity in transoral laser microsurgery compared to treatment with primary chemoradiation.

Level of evidence: 3.

Keywords: HPV‐mediated; Transoral laser microsurgery; oropharynx; squamous cell carcinoma; survival outcomes.

PubMed Disclaimer

Conflict of interest statement

We have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Five‐year overall survival of patients with oropharyngeal squamous cell carcinoma stratified by p16 status in early (blue) and late (red) stage disease. Due to small sample size (n = 11), p16 negative plots should be interpreted with caution.
FIGURE 2
FIGURE 2
Five‐year disease‐specific survival of patients with oropharyngeal squamous cell carcinoma stratified by p16 status in early (blue) and late (red) stage disease. Due to small sample size (n = 11), p16 negative plots should be interpreted with caution.
FIGURE 3
FIGURE 3
Five‐year local control of patients with oropharyngeal squamous cell carcinoma stratified by p16 status in early (blue) and late (red) stage disease. Due to small sample size (n = 11), p16 negative plots should be interpreted with caution.
FIGURE 4
FIGURE 4
Five‐year recurrence free survival of patients with oropharyngeal squamous cell carcinoma stratified by p16 status in early (blue) and late (red) stage disease. Due to small sample size (n = 11), p16 negative plots should be interpreted with caution.
FIGURE 5
FIGURE 5
(A) Trend in de‐escalation of adjuvant therapy by year. (B) Percentage of patients receiving 70, 66, and 60 Gy adjuvant radiation by year
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018;30(4):381‐395. doi:10.1016/j.coms.2018.06.001 - DOI - PubMed
    1. Johnson‐Obaseki S, McDonald JT, Corsten M, Rourke R. Head and neck cancer in Canada: trends 1992 to 2007. Otolaryngol Head Neck Surg. 2012;147(1):74‐78. doi:10.1177/0194599812437332 - DOI - PubMed
    1. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus‐related and ‐unrelated oral squamous cell carcinomas in the United States. JCO. 2008;26(4):612‐619. doi:10.1200/JCO.2007.14.1713 - DOI - PubMed
    1. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119(11):2620‐2623. doi:10.1002/ijc.22177 - DOI - PubMed
    1. Haughey BH, Hinni ML, Salassa JR, et al. Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011;33(12):1683‐1694. doi:10.1002/hed.21669 - DOI - PubMed

LinkOut - more resources